SOUTH SAN FRANCISCO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing next-generation chimeric antigen receptor (CAR) T-cell ...
Get key insights from Lucid Diagnostics' Q3 2025 earnings call, including Medicare coverage progress for EsoGuard and financial outlook.
L3Harris Technologies, Inc. has surged 33.3%, outperforming the S&P 500, driven by robust defense demand. Learn more about ...
Q3 2025 Management View CEO Arun Jeldi highlighted Velo3D’s transformation into a high-value recurring industrial technology platform, emphasizing "steady growth, operational improvement and expanding ...
Abstract: High-quality and diverse datasets are crucial for supervised learning in industrial defect detection, yet collecting such data remains challenging. Synthetic data generation offers a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback